These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11705525)

  • 1. Heterosexual transmission of HIV-1 infection in UK.
    Barbaro G
    Lancet; 2001 Oct; 358(9291):1458. PubMed ID: 11705525
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretrovirals and cardiovascular disease: is HAART bad for your heart?
    Fichtenbaum CJ
    AIDS Clin Care; 2003 Aug; 15(8):69-73, 76. PubMed ID: 12945527
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral therapy-associated diseases are common in the long-term.
    Lanzafame M; Lattuada E; Zoppini G; Vento S
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
    [No Abstract]   [Full Text] [Related]  

  • 4. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risks in HIV patients.
    Hedner T; Oparil S; Narkiewicz K; Os I
    Blood Press; 2010 Dec; 19(6):325-7. PubMed ID: 21080761
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly active antiretroviral therapy.
    Moerman F; Van Gompel A; Nimmegeers J; Moerman J
    BMJ; 2005 Jun; 330(7504):1341-2. PubMed ID: 15947375
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of highly active antiretroviral therapy on ischemic cardiovascular disease in patients with HIV-1 infection.
    Torre D; Pugliese A; Orofino G
    Clin Infect Dis; 2002 Sep; 35(5):631-2. PubMed ID: 12173141
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating late HIV diagnosis as a patient safety issue in the UK.
    Chadwick DR; Freedman A
    Lancet HIV; 2019 Jun; 6(6):e346-e348. PubMed ID: 31060875
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of cardiovascular risk in HIV patients: clinical implication.
    Das S
    Int J Clin Pract; 2010 Aug; 64(9):1173-5. PubMed ID: 20653794
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
    Calza L; Manfredi R; Pocaterra D; Chiodo F
    J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What happens to children growing up with HIV infection? It's time for a HAART to heart.
    Viganò A; Pattarino G; Cerini C; Zuccotti GV
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):495-8. PubMed ID: 19485788
    [No Abstract]   [Full Text] [Related]  

  • 12. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.
    Lipshultz SE; Mas CM; Henkel JM; Franco VI; Fisher SD; Miller TL
    Expert Rev Anti Infect Ther; 2012 Jun; 10(6):661-74. PubMed ID: 22734956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAART to heart talk.
    Huff B
    GMHC Treat Issues; 2003 Apr; 17(4):8-9. PubMed ID: 12751445
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increased cardiovascular risk in HIV patients].
    Wierema TK
    Ned Tijdschr Geneeskd; 2010; 154():A788. PubMed ID: 20456808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy.
    Currier JS; Lundgren JD; Carr A; Klein D; Sabin CA; Sax PE; Schouten JT; Smieja M;
    Circulation; 2008 Jul; 118(2):e29-35. PubMed ID: 18566319
    [No Abstract]   [Full Text] [Related]  

  • 17. Editors' perspective and conclusions.
    Lederman MM; Sereni D; Simonneau G; Voelkel NF
    AIDS; 2008 Sep; 22 Suppl 3():S63-7. PubMed ID: 18845924
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risk associated with HIV therapy.
    Currier JS
    J Acquir Immune Defic Syndr; 2002 Sep; 31 Suppl 1():S16-23; discussion S24-5. PubMed ID: 12218440
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pavia consensus statement.
    Volberding PA; Murphy RL; Barbaro G; Barbarini G; Bruno R; Cirelli A; Currie PF; Di Lorenzo G; Fantoni M; Filiced G; Galli M; Grisorio B; Moroni M; Recusani F; Sacchi P; Scevola D; Stein JH; Torre D; Vittecoq D
    AIDS; 2003 Apr; 17 Suppl 1():S170-9. PubMed ID: 12870544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.